ROCKVILLE, Md., Dec. 2, 2019 /PRNewswire/ — Emmes today announced that it is part of a team of medical centers, universities and private industry supporting the development of a “universal influenza vaccine” that could provide longer-lasting protection than current vaccines and combat a wider variety of influenza viruses.